USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/34792
Title: Cumulative burden index as a novel tool for long-term assessment of treatment outcomes in secondary neovascular glaucoma
Authors: Guzun, Olga
Zadorozhnyy, Oleg
Korol, Andriy
Keywords: glaucoma neovascular;glaucoma secondary;transscleral cyclophotocoagulation;Cumulative Burden Index (CBI);treatment burden;treatment outcome;prognosis;risk stratification;ROC curve
Issue Date: 2026
Publisher: Asociația Oftalmologilor din Moldova, Universitatea de Stat de Medicină și Farmacie ”Nicolae Testemițanu”
Citation: GUZUN, Olga; Oleg ZADOROZHNYY and Andriy KOROL. Cumulative burden index as a novel tool for long-term assessment of treatment outcomes in secondary neovascular glaucoma. In: Conferința anuală a oftalmologilor: carte de abstracte, 25-26 septembrie, 2026. Chișinău: CEP Medicina, 2026, p. 34. ISBN 978-9975-82-519-1 (PDF).
Abstract: Introduction/Objectives. Secondary neovascular glaucoma requires multiple therapeutic interventions, yet conventional outcome measures do not reflect cumulative treatment burden. This study evaluated the prognostic value of the Cumulative Burden Index (CBI) for long-term treatment outcomes. Materials and Methods. This prospective study included 224 eyes with secondary neovascular glaucoma treated with transscleral cyclophotocoagulation and followed for 36 months. The Cumulative Burden Index was calculated as an integrated measure incorporating the number of cyclophotocoagulation procedures and the severity of clinical complications. The prognostic performance of CBI was evaluated using multivariable logistic regression and receiver operating characteristic (ROC) analysis. Results. At 36 months, treatment success was achieved in 155 eyes (69.2%), whereas 69 eyes (30.8%) were classified as treatment failures. The mean CBI was significantly lower in the successful treatment group than in the failure group (3.9 vs. 6.6 points; p < 0.001). In the multivariable logistic regression model, CBI remained an independent predictor of unfavorable treatment outcome (OR = 1.58; 95% CI, 1.32–1.90; p < 0.001). ROC analysis demonstrated good predictive performance (AUC = 0.84; 95% CI, 0.79–0.89). A CBI threshold of ≥5 yielded a sensitivity of 78% and a specificity of 81%. Conclusions. The Cumulative Burden Index is an independent predictor of longterm treatment outcomes in secondary neovascular glaucoma. Quantification of cumulative treatment burden using CBI may improve risk stratification, facilitate personalized treatment planning, and support clinical decision-making in patients with secondary neovascular glaucoma.
metadata.dc.relation.ispartof: Conferinta anuală a oftalmologilor, 25-26 septembrie 2026, Chişinău
URI: https://repository.usmf.md/handle/20.500.12710/34792
ISBN: 978-9975-82-519-1 (PDF)
Appears in Collections:Conferința anuală a oftalmologilor: Carte de abstracte, 25-26 septembrie 2026, Chișinău

Files in This Item:
File Description SizeFormat 
CUMULATIVE_BURDEN_INDEX_AS_A_NOVEL_TOOL_FOR_LONG_TERM_ASSESSMENT_OF_TREATMENT_OUTCOMES.pdf210.3 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback